]>
IRCT20120215009014N494 IRCT 2024-01-02 Hamedan University of Medical Sciences Effect of proactive and retroactive medication reconciliation in the admission time on the reduction of medication error in patients with acute coronary syndrome Effect of proactive and retroactive medication reconciliation in the admission time on the reduction of medication error in patients with acute coronary syndrome: a randomized clinical trial study 2024-01-21 anticipated 162 Complete https://irct.ir/trial/74760 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Random allocation of patients to intervention and control groups by lottery. For this purpose, we prepare two sheets, write "intervention" on one and "control" on the other. Then, with each patient's visit, one of the sheets is randomly taken and the patient is assigned to the intervention or control group. 3 Acute coronary syndrome. Intervention 1: Intervention group: In the proactive group, after the patient is hospitalized and before the physician prescribes medication, the researcher prepares a complete history of the patient's medications by referring to the patient's bedside and provides them to the physician in order to prescribe medication according to the obtained medication history. Intervention 2: Control group: In the retroactive group, after the patient is hospitalized and the physician prescribes medication, the researcher prepares a complete history of the patient's medications by referring to the patient's bedside, and then the perform medication integration (including the medications prescribed by the physician and previous medications of the disease). Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is It depends on the situation and the results of the study as well as the approval of the financial supporting organization.
public Mahdiyeh Fateminejad
School of Pharmacy, Hamadan University of Medical Sciences, Fahmideh Ave.
Hamadan Iran (Islamic Republic of) 6517838695 +98 81 3838 0572 mahdiyehfateminjd@gmail.com Hamedan University of Medical Sciences scientific Dr. Maryam Mehrpooya
School of Pharmacy, Hamadan University of Medical Sciences, Fahmideh Ave.
Hamadan Iran (Islamic Republic of) 6517838695 +98 81 3838 0572 m_mehrpooya2003@yahoo.com Hamedan University of Medical Sciences Iran (Islamic Republic of) Age of 18 to 70 years Taking at least 5 medications per day, including medications with high interactions or with a narrow therapeutic window 18 years 70 years Both Discharge in less than 24 hours Hospitalization in the evening or night shift or on holidays I24.0 Acute coronary thrombosis not resulting in myocardial infarction Other Other Intervention group: In the proactive group, after the patient is hospitalized and before the physician prescribes medication, the researcher prepares a complete history of the patient's medications by referring to the patient's bedside and provides them to the physician in order to prescribe medication according to the obtained medication history. Control group: In the retroactive group, after the patient is hospitalized and the physician prescribes medication, the researcher prepares a complete history of the patient's medications by referring to the patient's bedside, and then the perform medication integration (including the medications prescribed by the physician and previous medications of the disease). Inconsistencies and medication errors. Timepoint: In the first 24 hours of hospitalization. Method of measurement: By taking history and reviewing the medical record. Hamedan University of Medical Sciences Approved 2023-12-30 Ethics Committee of Hamadan University of Medical Sciences Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences, Fahmideh Ave Hamadan Hamadan Iran (Islamic Republic of)